T
TRANSCODE THERAPEUTICS INC
NASDAQ: RNAZ (TransCode Therapeutics, Inc.)
Kemas kini terakhir: 22 jam lalu1.69
0.00 (0.00%)
| Penutupan Terdahulu | 1.69 |
| Jumlah Dagangan | 11,441 |
| Harga / Buku (P/B) | 2.83 |
| Julat 52 Minggu |
| EPS Cair (TTM) | -792.40 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 9.23% |
| Nisbah Semasa (MRQ) | 5.20 |
| Aliran Tunai Operasi (OCF TTM) | -12.50 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -7.16 M |
| Pulangan Atas Aset (ROA TTM) | -94.84% |
| Pulangan Atas Ekuiti (ROE TTM) | -342.99% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | TransCode Therapeutics, Inc. | Bercampur | Bercampur |
AISkor Stockmoo
0.2
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 3.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.5 |
| Purata | 0.17 |
|
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 0.15% |
| % Dimiliki oleh Institusi | 9.16% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Yorkville Advisors Global, Lp | 30 Jun 2026 | 19,639 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |